BA
GILD icon

Bennicas & Associates’s Gilead Sciences GILD Stock Holding History

Bennicas & Associates’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$1.47M Sell
17,166
-100
-0.6% -$7.92K 0.85% 42
2022
Q3 		$1.06M Sell
17,266
-875
-5% -$55.2K 0.68% 49
2022
Q2 		$1.12M Sell
18,141
-100
-0.5% -$6.19K 0.65% 52
2022
Q1 		$1.08M Sell
18,241
-125
-0.7% -$7.99K 0.54% 58
2021
Q4 		$1.33M Sell
18,366
-525
-3% -$36.2K 0.69% 47
2021
Q3 		$1.32M Hold
18,891
– – 0.74% 48
2021
Q2 		$1.3M Buy
18,891
+600
+3% +$40.1K 0.72% 52
2021
Q1 		$1.18M Sell
18,291
-150
-0.8% -$9.67K 0.68% 56
2020
Q4 		$1.07M Sell
18,441
-1,400
-7% -$84.5K 0.63% 57
2020
Q3 		$1.25M Buy
19,841
+66
+0.3% +$4.58K 0.78% 45
2020
Q2 		$1.52M Sell
19,775
-25
-0.1% -$1.92K 1.14% 31
2020
Q1 		$1.48M Sell
19,800
-800
-4% -$55.3K 1.31% 27
2019
Q4 		$1.34M Sell
20,600
-800
-4% -$52.1K 0.97% 42
2019
Q3 		$1.36M Sell
21,400
-150
-0.7% -$9.8K 1.05% 37
2019
Q2 		$1.46M Sell
21,550
-200
-0.9% -$13.2K 1.21% 30
2019
Q1 		$1.41M Hold
21,750
– – 1.24% 31
2018
Q4 		$1.36M Hold
21,750
– – 1.25% 29
2018
Q3 		$1.68M Hold
21,750
– – 1.46% 19
2018
Q2 		$1.54M Hold
21,750
– – 1.37% 25
2018
Q1 		$1.64M Sell
21,750
-550
-2% -$43.7K 1.46% 19
2017
Q4 		$1.6M Sell
22,300
-300
-1% -$22.8K 1.39% 23
2017
Q3 		$1.83M Hold
22,600
– – 1.56% 16
2017
Q2 		$1.6M Buy
22,600
+100
+0.4% +$6.65K 1.43% 23
2017
Q1 		$1.53M Sell
22,500
-200
-0.9% -$14.1K 1.36% 25
2016
Q4 		$1.63M Buy
+22,700
New +$1.69M 1.47% 22

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bennicas & Associates's GILD Position: Q4 2022 in Review

Bennicas & Associates reduced its Gilead Sciences (GILD) stake by 0.58% in Q4 2022, selling an estimated $7.92K and leaving 17,166 shares worth $1.47M. The position accounts for 0.85% of the portfolio, ranked #42.

Bennicas & Associates first reported a position in GILD in Q4 2016 and has held it in 25 quarters since. The position peaked at $1.83M in Q3 2017. 1,767 funds tracked by Wall St. Rank hold GILD as of Q4 2022.

  • Bennicas & Associates held 17,166 shares of Gilead Sciences worth $1.47M as of Q4 2022.
  • Bennicas & Associates sold 100 Gilead Sciences shares in Q4 2022, an estimated $7.92K.
  • Gilead Sciences made up 0.85% of Bennicas & Associates's portfolio in Q4 2022, its #42 holding.
  • Bennicas & Associates first reported a position in Gilead Sciences in Q4 2016 and has held it in 25 quarters since.
  • Bennicas & Associates's Gilead Sciences position peaked at $1.83M in Q3 2017.
  • 1,767 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2022.

Based on Bennicas & Associates's 13F filing for Q4 2022, filed 12 Jan 2023.